Navigation Links
Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Date:5/16/2012

ecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative.  Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective f
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
2. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
3. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
7. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
8. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015 Research and ... the addition of the "Global Next Generation ... The global next generation sequencing market ... the period 2014-2019 This report covers ... the global next generation sequencing market for the ...
(Date:5/21/2015)... SEATTLE , May 21, 2015 Sarcos ... sensors and medical devices, announced today the appointment of ... Officer and head of Corporate Development effective immediately.  Woo ... development and finance roles, including positions at UBS Investment ... Woo will be located in Sarcos, Seattle ...
(Date:5/21/2015)... , May 21, 2015 /CNW/ - Canadians face wait times of ... lifesaving medicines in public drug plans, according to a new ... Canada 16 out of 18 similar OECD ... 23% of 141 Health Canada-approved new medicines were included in public ... on this front," said Brett Skinner , Rx&D Executive Director, ...
Breaking Medicine Technology:Global Next Generation Sequencing Market 2015-2019 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2Canadians lagging well behind similar countries on access to new medicines: report 2Canadians lagging well behind similar countries on access to new medicines: report 3
... N.Y. Feb. 7, 2011 BioSpecifics Technologies Corp. (Nasdaq: ... biopharmaceutical company developing first in class collagenase-based products, today ... Rights Agreement (the "Rights Agreement"), adopted May 14, 2002 ... The Amendment increases the ownership threshold for determining ...
... start-up, UrgentRx , today announced the launch of ... credit card-sized packets, including UrgentRx Aspirin to Go ... first aid.  February is the American Heart Association,s ... UrgentRx Aspirin to Go timely as research supports the ...
Cached Medicine Technology:UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado 2UrgentRx Launches Line of Innovative and Portable, Fast-Acting Medications Across Colorado 3
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
(Date:5/22/2015)... May 22, 2015 In efforts to ... the section containing particular muscles stretches has been a ... 50% of stretches now complete, Chunk Fitness envisions a ... to be filmed and released at a later point ... found here: http://www.chunkfitness.com/stretches . , About the Company: ...
(Date:5/21/2015)... New York, New York (PRWEB) May 21, 2015 ... and distributor of patented products, launches the Troll Motor ... more convenient way of boating. , "The recreational boating ... says Scott J. Cooper, CEO and Creative Director of ... the water in record numbers and predicts continued steady ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... ... and distribute the QuickMAR e-charting software with its electronic medication management systems. , ... (PRWEB) January 26, 2010 ... easily and accurately manage patient medications, with today’s announcement of a joint distribution agreement ...
... publication in The Endocrine Society,s Journal of Clinical ... commonly used forms of antidepressant drugs may experience delayed ... to achieve their breastfeeding goals. Breastfeeding benefits ... milk is easy to digest and contains antibodies that ...
... ... tips for safer driving on icy highways. , ... New York, NY (PRWEB) January 26, 2010 -- When rain falls or ... personal injury attorney says., , ,“Black ice is as dangerous as it is difficult to ...
... ... is pleased to announce that they are now offering Trek’s Ride+ electric assist bikes to their ... and battery, Trek Travel is opening up a new world of cycling vacations to a wider ... ...
... ... an industry leader in Continuous Process Improvement (CPI) Training and Certification, took ... battle tough economic times, they made their On Demand Lean Six Sigma ... hundreds of organizations to learn the basics of Lean Six Sigma, but ...
... , , WASHINGTON , Jan. 25 ... guilty today for her role in a Detroit -area home ... of the Criminal Division; U.S. Attorney for the Eastern District ... Arena of the FBI,s Detroit Field Office; and Special Agent in ...
Cached Medicine News:Health News:Medicine-On-Time Partners With QuickMAR to Streamline Medication Management and Improve Patient Care 2Health News:Medicine-On-Time Partners With QuickMAR to Streamline Medication Management and Improve Patient Care 3Health News:Common antidepressant drugs linked to lactation difficulties in moms 2Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 2Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 3Health News:Driving Danger -- Black Ice Poses Menace on Frigid NY Roadways, New York Attorney Steven J. Schwartzapfel Says 4Health News:Trek Travel Introduces Trek's Ride+ Electric Assist Bikes to Cycling Vacations 2Health News:Mountain Home Experiences a Huge Response to Their Ground Breaking Free Lean Six Sigma Certification Offer 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 3
... ENA Profile-6 ELISA test system is a ... antibodies to Jo-1, Sm, Sm/RNP, SSA, SSB, ... according to the directional insert, the results ... the diagnosis and treatment of autoimmune connective ...
Inquire...
... The K-ASSAY Microalbumin Urine Controls ... to use liquid requiring no ... prepared from human urine, fortified ... albumin and creatinine. Preservatives including ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: